Avitar, Inc. (AVTI)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT
Avitar Revenue
Avitar had revenue of $505.39K in the quarter ending December 31, 2007, a decrease of -46.73%. This brings the company's revenue in the last twelve months to $2.66M, down -41.61% year-over-year. In the fiscal year ending September 30, 2007, Avitar had annual revenue of $3.11M, down -31.26%.
Revenue (ttm)
2.66M
Revenue Growth
-41.61%
P/S Ratio
0.00
Revenue / Employee
73.97K
Employees
36
Market Cap
731.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2007 | 3.11M | -1.41M | -31.26% |
Sep 30, 2006 | 4.52M | 10.13K | 0.22% |
Sep 30, 2005 | 4.51M | 460.37K | 11.37% |
Sep 30, 2004 | 4.05M | -549.48K | -11.95% |
Sep 30, 2003 | 4.60M | -3.69M | -44.55% |
Sep 30, 2002 | Pro | Pro | Pro |
Sep 30, 2001 | Pro | Pro | Pro |
Sep 30, 2000 | Pro | Pro | Pro |
Sep 30, 1999 | Pro | Pro | Pro |
Sep 30, 1998 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |